Showing results 1 to 20 of 27
next >
| Issue Date | Title | Author(s) | Type | Мp-cat. |
| 2019 | Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries | Wilking, Nils; Bucsics, Anna; Kandolf-Sekulovic, Lidija O; Kobelt, Gisela; Laslop, Andrea; Makaroff, Lydia; Roediger, Alexander; Zielinski, Christoph | Article | |
| 2025 | Clinical outcomes in patients with melanoma brain metastases: First-line treatment options | Mangana, J; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 19) | Conference Paper | |
| 2023 | Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox study | L'Orphelin, J-M; ...; Kandolf-Sekulovic, Lidija O; ...; Dujovic, B; ...; (broj, koautora 22) | Article | |
| 2019 | Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC) | Lebbe, Celeste; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 23) | Article | |
| 2019 | Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers | Dessinioti, Clio; ...; Kandolf-Sekulovic, Lidija O; Radević, Tatjana   ; ...; (broj, koautora 41) | Научни чланак | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |
| 2024 | Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial | Schadendorf, Dirk; ...; Kandolf-Sekulovic, Lidija O; ...; Mijusković, Željko P. ; ...; (broj, koautora 20) | Конференцијски рад | |
| 2022 | Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAF(V600)-positive melanoma: Interim analysis of the ImmunoCobiVem study. | Schadendorf, Dirk; ...; Kandolf-Sekulovic, Lidija O; ...; Mijuskovic, Željko P ; ...; (broj, koautora 20) | Conference Paper | |
| 2022 | EMRseq: Registry-based outcome analysis on 1,000 patients with BRAF V600-mutated metastatic melanoma in Europe treated with either immune checkpoint or BRAF-/MEK inhibition. | Weichenthal, Michael; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 20) | Conference Paper | |
| 2023 | European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023 | Stratigos, Alexander J; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 35) | Article | |
| 2023 | European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023 | Stratigos, Alexander J; ...; Hauschild, Axel; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 40) | Article | |
| 2020 | European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention | Stratigos, Alexander J; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 28) | Article | |
| 2020 | European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment | Stratigos, Alexander J; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 28) | Article | |
| 2003 | Immunomodulatory effects of low-intensity near-infrared laser irradiation on contact hypersensitivity reaction | Kandolf-Sekulovic, Lidija O; Kataranovski, Milena V ; Pavlovic, Milos D | Article | |
| 2015 | Lymphoscintigraphy and Sentinel Lymph Node Biopsy in Cutaneous Melanoma: Analysis of 201 Patients From a Single Institution | Jaukovic, Ljiljana Dj; Rajovic, Milica I; Radulovic, Marija; Kandolf-Sekulovic, Lidija O | Conference Paper | |
| 2018 | Major determinants of delayed access to innovative medicines for metastatic melanoma: The results of Melanoma World Society and European Association of Dermato-Oncology survey | Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 20) | Conference Paper | |
| 2019 | MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort | Pellegrini, Cristina; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 190) | Article | |
| 2016 | More than 5000 patients with metastatic melanoma in Europe per year do not have access to new life-saving drugs | Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 20) | Conference Paper | |
| 2022 | Outcome of PD-1 inhibitor therapy of advanced melanoma patients according to demographic factors in a real-world setting across Europe | Weichenthal, Michael; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 20) | Conference Paper | |
| 2023 | Prediction of Additional Regional Lymph Node Metastases in Cutaneous Melanoma Patients With Positive Sentinel Lymph Node Biopsy | Radosavcev, L; Rajovic, Milica I; Radulovic, Marija; Petrov, Nenad; Kandolf-Sekulovic, Lidija O | Conference Paper | |
| 2022 | Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment | Garbe, Claus; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 27) | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |